APPLICATIONS PUBLISHED 8 JUNE 2005

Published: 11-Oct-2006

Heterocarpin, a plant-derived protein with anti-cancer properties
Societe de Conseils de Recherches et d'Applications Scientifiques 1536808*


Heterocarpin, a plant-derived protein with anti-cancer properties
Societe de Conseils de Recherches et d'Applications Scientifiques 1536808*

Use as fermented wheat germ extract as anti-inflammatory agent
Hidvegi, Mate 1536809*

Extraction of pharmaceutically active cannabinoids from plant materials
GW Pharma 1536810*

Extraction and purification method of active constituents from stem of Lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug
SK Chemicals 1536811*

Methods for modulating activity of the FXR nuclear receptor
City of Hope 1536812*

Compsns and methods comprising protein activated receptor antagonists
EntreMed 1536813*

ANTibodies to non-shed MUC1 and MUC16, and uses thereof
Immunogen 1536814*

Angio-immunotherapy
Duke University 1536815*

Amelioration of effects of cigarette smoke
Witten, Mark; Harris, David 1526816*

Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia
Gestion Univalor Societe en Commandite 1536817*

Fibrinogen binding moieties
Dyax 1536818*

Use of ROM Production and release inhibitors to treat and prevent intraocular damage
Maxim Pharmaceuticals 1536819*

Cancer therapy using whole glucan particles and antibodies
Biopolymer Engineering; University of Louisville Research Foundation 1536820*

Inhibition of T cell activation by butyrophilin 4 or B7-L1
Wyeth 1536821*

Stable pharmaceutical compsn comprising erythropoietin
LEK Pharmaceuticals DD 1536822*

Use of erythropoietin
F Hoffmann-La Roche 1536823*

Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system
University of Miami, Office of Technology Transfer; Universitaet Heidelberg 1536824*

Interferon and immunoglobulin FC fragment hybrid
Tanox 1536825*

Thymus-based tolerogenic approaches for type I diabetes
Universite de LiEge 1536826*

Use of protein kinase N beta
Atugen 1536827*

Methods of delivery of exogenous proteins to the cystol and uses thereof
President and Fellows of Harvard College; The General Hospital Corp 1536828*

Methods for preparing compsns comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
University of Connecticut Health Centre 1536829*

Vaccine for respiratory and reproductive system infections in cattle
Pfizer Products 1356830*

Pharmaceutical liposomal compsns containing N. meningitidis derived polypeptides or polynucleotides
ID Biomedical 1536831*

Flagellin peptides as adjuvants for vaccines
Fondation Eurovacc 1536832*

Vaccine against Yersinia comprising one or two antibodies, one specific for Yersina pestis F1-antigen and the other one for Yersina pestis V-antigen
The Secretary of State for Defence, DSTL Porton Down 1536833*

Design for chemokine analogues for the treatment of human diseases
Chemokine Therapeutics 1536834*

Liquid formulations with high concentration of human growth hormone (HGH) comprising phenol
Sandoz 1536835*

Topical emulsion-gel compsn comprising diclofenac sodium
Novartis Consumer Health 1536836*

Compsn for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
Bio Syntech Canada 1536837*

Conjugated hydroxylakyl starch allergen compounds
Fresenius Kabi Deutschland 1536838*

Method for treating diseases with omega interferon
Intarcia Therapeutics 1536839*

Formulation for inwardly transferring nucleic acids into eukaryotic cells
Avontec 1536840*

Monitoring and diagnosis of gastric emptying and gastroparesis
The University of Chicago 1536841*

Methods for functional kidney imaging using dendrimer conjugate contrast agents
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1536842*

Radiolabelled compounds and liposomes and their methods of making and using the same
Board of Regents of the University of Texas System 1536843*

Preparation of M(CO)3-complexes by solid phase techniques via metal assisted cleavage from the solid support
University of Zurich 1536844*

Wound dressing materials comprising complexes of anionic polysaccharides with silver
Johnson & Johnson 1536845*

Active agent delivery system including a polyurethane, medical device, and a method
Medtronic 1536846*

Analogues of vitamin D
Galderma Research & Development 1537065*

Improvements in pharmaceutically useful compounds
Charterhouse Therapeutics 1537066*

Resolvins: biotemplates for therapeutic interventions
Brigham and Women's Hospital 1537067*

Materials and methods for treating hypercholesterolemia
Aryx Therapeutics 1537068*

Analogues of lipid mediators derived from omega-3 pufas and methods of use
Resolvyx Pharmaceuticals 1537069*

Process for preparing nitorxyalkyl substituted estes of carboxylic acids, intermediates useful in said process and preparation thereof
Nicox 1537070*

Method for the production of optically active 2-amino-, 2-chloro-, 2-hydroxy or 2-alkoxy-1-alcohols
BASF 1536071*

Substituted aminoethers for the treatment of Alzheimer's disease
Pharmacia & Upjohn 1537072*

Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
Karo Bio; Bristol-Myers Squibb 1537073*

Cathepsin cysteine protease inhibitors
Merck Frosst Canada 1537074*

Diarylurea derivative and their use as chloride channel blockers
Neurosearch 1537075*

Novel vinyl carboxylic acid derivatives and their therapeutic use
Novo Nordisk 1537076*

4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
Syngenta Participations 1537077*

Indoles having antidiabetic activity
Merck 1537078*

Phenyl-indole compounds for modulating IGE and inhibiting cellular proliferation
Avanir Pharmaceuticals 1537079*

Substituted spirocyclic ketoenols
Bayer CropScience 1537080*

Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
Bayer HealthCare 1537081*

Processes for the preparation of S-(-)-amlodipene
Hanlim Pharmaceutical 1537082*

S-(-)-amlodipine nicotinate and processes for the preparation thereof
Hanlim Pharmaceuticals 1537083*

Substituted 2-alkylamine nicotinic amide derivatives and use thereof
Amgen 1537084*

Oxytocin inhibitors
Pfizer 1537085*

Novel phenanthridines
Altana Pharma 1537086*

Novel aminoindazole derivatives as medicines and pharmaceutical compsns containing same
Aventis Pharma 1537087*

Compounds, compsns and methods
Cytokinetics 1537089*

Chromone derivatives as matrix metalloproteinase inhibitors
Warner-Lambert 1537090*

Novel 2-arylthiazole compounds as PPARalpha and PPARgamma agonists
F Hoffmann-La Roche 1537091*

Taxane derivatives functionalised at the 14-position and a process for the preparation thereof
Indena 1537093*

Methods and compsns for converting taxane amides to paclitaxel or other taxanes
Natural Pharmaceuticals 1537094*

Process for preparing functionalised butyrolactiones from mucohalic acid
Warner-Lambert 1537095*

Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
Sanofi-Aventis 1537096*

Method of preparing 3-halo-4,5-dihydro-1 H-pyrazoles
EI du Pont de Nemours 1537097*

Monocyclic derivatives as matrix metalloproteinase inhibitors
Warner-Lambert 1537098*

Pyrrole based inhibitors of glycogen synthase kinase 3
Chiron 1537099*

Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors
Altana Pharma 1537100*

You may also like